Alright, Ginny & Georgia fans, let’s talk about the big question: Is Season 4 of Ginny & Georgia actually happening? After that wild Season 3 finale on Netflix (June 5, 2025, anyone?), we’re all dying ...

Jefferies reiterated its ‘Buy’ rating on the stock with a target price of ₹100, stating that a higher HRAB could significantly enhance allowable tariff recovery and profitability for DIAL, addressing ...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd and a leading global biosimilars company, has received marketing authorisation from the European Commission (EC) for its biosimilars Vevzuo® and ...

The hotel is scheduled to open in November 2025 and will be called Garner Hotel Kyoto Shijo Karasuma, following an extensive interior renovation with strong Kyoto design influences. It will be the ...

Since 1963, the company has stood for quality, innovation, and value, empowering professionals across industries with a wide range of reliable power tools, hand tools, and accessories. The new brand ...

Walko Food Company has acquired Mumbai-based Meemee’s Ice Creams to expand into India’s artisanal dessert market. Known for quirky offerings like Toasties and Tubsters, Meemee’s strengthens Walko’s ...

Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Prucalopride Tablets, 1 mg and 2 mg. These ...

Several leading brokerages have updated their ratings and target prices on key Indian stocks, reflecting their latest outlooks and expectations. Here’s a round-up of key stock calls to watch: UBS has ...

CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has received marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for ...

CitiusTech, a leading healthcare technology solutions provider, has appointed Navneet Khandelwal as its Chief Financial Officer (CFO). With nearly 25 years of experience in IT services, Khandelwal ...

Glenmark Pharmaceuticals has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its entry into the immuno-oncology space. This anti-PD-1 monoclonal antibody, developed by global ...

XRP News: Vaultro Finance Presale on XRP Enters Final 5 Days with 75% of $VLT Tokens Claimed – Join $VLT Presale ...